Health Care Equipment & Services

Discover how Carl Zeiss Meditec AG dominates ophthalmology tech, drives global eye‑care innovation, and delivers strong investor returns.

Explore how Lumos Diagnostics’ performance-rights securities were discontinued—yet the company’s point‑of‑care diagnostics and ASX trading remain robust.

Top Glove champions community sport at the Lightning Cup, boosting its CSR image while navigating tough healthcare supply‑chain and market pressures.

Blue Sail Medical surges as China’s medical‑device boom heats up: policy lift, earnings rebound, and ETF rally signal a new high‑growth era for the firm.

Boston Scientific’s stock rebounds to $44.65 amid market volatility, showcasing its robust portfolio of minimally invasive devices and promising growth prospects for investors.

Explore Zentek Ltd.’s pioneering graphene composites—merging health care and construction tech—while weighing its TSX stock’s growth potential and R&D focus.

Discover how Calgary‑based VentriPoint Diagnostics is revolutionizing heart disease detection with 3‑D imaging tech and AI‑powered models—boosting accuracy and early care.

Intuitive Surgical’s earnings reveal the future of surgical tech: market‑cap $144B, 49.44 P/E, and analyst‑surprise potential amid economic uncertainty.

Hedera Group AB: Stockholm-based health‑care staffing firm with a 16.95 M SEK market cap, current price 0.50 SEK, and a long‑term high‑risk outlook driven by digital recruitment and AI matching.

Insider sales at BillionToOne, Inc. reveal strategic divestment and regulatory compliance, while its $5.43B market cap and high PE signal future growth potential.